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Benefit of immediate revascularization in women
with critical limb ischemia in an intention-to-treat
analysis
Jana Ortmann, MD,a Eveline Nüesch, PhD,d Gian Cajöri, BS,a Nicolas Diehm, MD,a Florian Dick, MD,b
Tobias Traupe, MD,c and Iris Baumgartner, MD,a Bern, Switzerland
Background: Evidence for the best treatment strategy in women with critical limb ischemia (CLI) is limited and
controversial with studies contradicting each other. Therefore, we determined the benefit of immediate revascular-
ization compared to medical therapy (MT) with optional delayed revascularization in men and women with CLI.
Methods: This cohort study with follow-up at 2, 6, and 12 months was conducted in a consecutive series of 356 patients
(41% women) presenting with 394 critically ischemic limbs. In this intention-to-treat study, 292 limbs were assigned to
immediate revascularization by either surgical (81 limbs) or endovascular techniques (211 limbs) at the time of first
presentation with CLI, whereas MT as first-line therapy was administered in 102 limbs with CLI. Primary outcome
measures were overall and amputation-free survival. Cox-regression models adjusted for 10 baseline characteristics
following Kaplan–Meier Survival estimates were performed.
Results: Women with CLI were significantly older than men (P< .001), had higher systolic blood pressure (P .03) and
cholesterol levels (P  .04), but less women presented with renal failure (P  .03) and less were smokers (P < .001). In
women, but not in men, immediate revascularization was associated with a prolonged overall survival (hazard ratio [HR],
2.37; 95% confidence interval [CI], 1.29-4.34; P  .01) and amputation-free survival compared to MT (HR, 2.11; 95%
CI, 1.30-3.43; P .01), irrespective of whether surgery or percutaneous transluminal angioplasty (PTA) was performed
(not significant). Except for overall survival (HR, 2.14; 95% CI, 0.95-4.82; P  .07), outcomes were not significantly
changed after Cox regression analysis.
Conclusion: Women presenting with CLI profit from immediate revascularization therapy, irrespective of revasculariza-
tion technique used and despite advanced age and differences in other cardiovascular risk factors. Thus, our data suggest
aggressive and early limb salvage efforts in women with CLI. (J Vasc Surg 2011;54:1668-78.)
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gChronic critical limb ischemia (CLI), also considered
as the “endstage” of peripheral artery disease, represents
the most severe form of peripheral artery disease in which
rest pain, ulceration, or gangrene heralds potential limb
loss.1 Patients with CLI are at an exceptionally high risk
for cardiovascular events, and CLI is associated with an
increased mortality if left untreated.1 Therefore, ap-
proaches to optimize current therapeutic standards are of
high priority. Currently, immediate revascularization is
the recommended primary treatment option for patients
with CLI, with technical feasibility and beneficial out-
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1668omes shown for both surgical and endovascular proce-
ures.1-7
Most studies comparing conservative or revascularization
herapies were not analyzed by gender or have been per-
ormed predominantly in men,2,3 and clinical trials investigat-
ng either surgical or endovascular revascularization therapy
nly demonstrated worse outcomes in women.4-6,8 These
orse outcomes have been ascribed to smaller vessel diameter,
dvanced age, and comorbidities, and especially to general-
zed severe cardiovascular burden in women with subsequent
igher pre-interventional and peri-interventional risk.4,6,9-11
dditional factors inherent for women after menopause may
lso be responsible for adverse outcomes.12 Women develop
therosclerotic disease later in life and the atherosclerotic
isease process seems to progress rapidly after menopause
hen protective effects of estrogens are lost.13,14
The position article of the American Medical Women’s
ssociation states that only 25% of research studies were
nalyzed by gender.15 However, since the United States
ational Institutes of Health strongly recommended inclu-
ion of women in clinical research, gender differences in
ardiovascular disease have gained increased attention. In
act, gender-dependent effects on the outcome of immedi-
te revascularization vs medical therapy have been shown
or cerebrovascular and acute coronary artery disease, and
ender-specific treatment guidelines have been pub-
ished.16,17
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Volume 54, Number 6 Ortmann et al 1669Because the optimal treatment strategy for female pa-
tients with CLI is controversial, we retrospectively assessed
clinical characteristics and outcome of women from a pro-
spectively collected cohort study.18 The primary goal was
to determine the benefit of immediate revascularization
compared to medical therapy (MT) with or without de-
layed revascularization in men and women with CLI.
METHODS
Study design. The study design of this trial has been
described previously.18 Briefly, all patients with chronic
CLI presenting to the Swiss Cardiovascular Center at the
University Hospital, Bern, Switzerland, between January
1999 and June 2004, were prospectively followed for 12
months. Recorded patient details included demographic
characteristics, risk factors, clinical presentation, imaging
studies, treatment modality at baseline, and prospective
follow-up data at 2, 6, and 12 months. Primary end points
were overall and amputation-free survival. Secondary end
points consisted of limb salvage and sustained clinical suc-
cess, defined as clinical improvement without the need for
repeated target extremity revascularization (TER) and
without major amputation. Clinical improvement was de-
fined according to Rutherford (ie, a categorical upward
shift of at least 1 clinical category) for all categories except
for baseline category 5 (upward shift of at least 2 clinical
categories) in combination with a hemodynamic improve-
ment of either ankle-brachial index (ABI) or toe-brachial
index (both of at least 0.1) or oscillometric reading. Defi-
nition of CLI followed current consensus at inclusion time:
(1) presence of ischemic rest pain for2 weeks or ischemic
tissue loss associated with (2) an absolute ankle pressure of
50 mm Hg and/or great toe pressure of 30 mm
Hg.19,20 Patients with acute limb ischemia were excluded.
Approval of the cantonal ethics committee was obtained
(Ministry of Health, Canton of Bern, Switzerland, KEK-
No. 108/02). The study was conducted according to the
Declaration of Helsinki and all patients gave informed
consent before inclusion into the study.
Data collection. Complete noninvasive vascular workup
was performed at baseline and at each of the follow-up visits
and included calculation of ABI. Transcutaneous oxygen
tension (TcPO2) and great toe pressure and oscillometric
measurements were performed when pedal arteries were
incompressible or pressures were not detectable.21 Im-
aging studies were limited to patients with clinical suspi-
cion of recurrent stenosis, occlusion, or de-novo arterial
obstruction. Grading of the severity of clinical disease
followed the classification system proposed by Ruther-
ford.20
Treatment decision. All patients were evaluated on a
case-by-case basis by a dedicated multidisciplinary vascular
board, including interventional angiologists, radiologists,
and vascular surgeons established according to interna-
tional recommendations.22 Departmental guidelines for
optimal treatment were continuously adapted to recom-
mendations at inclusion time.19,22 Treatment decision at
baseline and during follow-up was determined by clinical Mresentation, urgency of therapy, general condition of the
atient (such as presence of limiting comorbidities) as well
s morphologic nature of vascular lesions (including ana-
omic distribution, availability of autologous veins, and
ccess for endovascular therapy).23 Medical therapy in-
luded analgesic, antibiotic, antiplatelet, and antithrom-
otic therapy, as well as prostaglandins (infrequently). Risk
actors were treated with lipid-lowering, antihypertensive,
nd antidiabetic drugs.23,24 Immediate revascularization
as defined as revascularization procedure performed as
oon as possible but not later than 30 days after diagnosis.
ecisions on repeated extremity revascularizations were
nvariably based on vascular imaging in addition to clinical
ndings. These included presence of ischemic rest pain or
rogressive ischemic tissue loss associated with an absolute
nkle pressure of50 mmHg and/or great toe pressure of
30mmHg. Patients who underwent primary amputation
wing to irreversible ischemic damage were registered for
escriptive analysis but were excluded from the study.
Treatment cohorts. Patients were included into one
f the following cohorts according to the primary therapeu-
ic decisions at first presentation with CLI in our center
intention-to-treat analysis): (1) MT with optional delayed
evascularization; or (2) immediate revascularization, in-
luding bypass surgery and percutaneous transluminal an-
ioplasty (PTA) with or without stenting. MT was applied
qually to all treatment cohorts at the time of diagnosis and
onsisted of the above-mentioned pharmacologic treat-
ent.
Definitions. The following definitions were used: ar-
erial hypertension was assumed if systolic blood pressure
as140 mmHg or diastolic90 mmHg at least on two
ifferent occasions, or if the patient was taking antihyper-
ensive medication. Dyslipidemia was defined by a total
erum cholesterol level of 5 mmol/L (190 mg/dL),
erum high density lipoprotein cholesterol level of 1
mol/L (40 mg/dL), or serum triglyceride level of 2
mol/L (180 mg/dL) and was assumed if a patient was
aking lipid-lowering drugs. Diabetes mellitus was defined
y fasting blood sugar levels 120 mg/dL, a hemoglobin
1c level 6%, or intake of antidiabetic drugs. Current
moking habits were divided into either smoking or non-
moking. Renal failure was defined by serum creatinine
evels130mol/L. ABI was calculated by the ratio of the
ighest systolic arterial pressure reading of both tibial ar-
eries and brachial artery blood pressure. Tibial artery in-
ompressibility was assumed when ABI was1.15 because
his cut-off value has been reported to be invariably associ-
ted with heavy continuous calcification of tibial vessels.21
mputations were considered major and thus registered if
erformed above the ankle. The combined end point
mputation-free survival was defined as survival without
mputation.
Statistical analysis. Kaplan-Meier estimates of cu-
ulative probabilities of overall and amputation-free
urvival, limb salvage, and sustained clinical success were
alculated separately for immediate revascularization and
T in all patients and analyzed separately by gender. We
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December 20111670 Ortmann et alused univariable and multivariable Cox proportional
hazard models that accounted for the clustering of limbs
within patients to compare rates of all primary and
secondary end points between immediate revasculariza-
tion and MT in all patients and stratified by gender.
Multivariable Cox models were adjusted for age, diabe-
tes, hypertension, smoking, renal failure, dialysis, hyper-
lipidemia, intake of anticoagulants or platelet inhibitors,
and clinical symptoms according to Rutherford at base-
line. In a sensitivity analysis, we compared reconstructive
surgery to PTA in all patients and separately in men and
women. Gender differences of primary and secondary
outcomes were assessed by Cox regression models, in-
cluding interaction terms between gender and interven-
tion. Baseline characteristics were compared between
limbs with immediate revascularization and medical
therapy using Wald tests derived from univariable linear
or logistic regression models that accounted for the
clustering of limbs within patients. All P values and 95%
Fig 1. Decconfidence intervals (CIs) were two-sided. uESULTS
Cohort description. During the study period, 383
onsecutive patients with 426 chronic critically ischemic
imbs (41% were women) presented at our Swiss Cardio-
ascular Center, a tertiary referral center for a population of
bout 1.1 million people. Thirty-two limbs were excluded
rom analysis and 394 limbs of 356 patients (41% women)
ere finally accepted for analysis (Fig 1). Immediate revas-
ularization was performed in 292 limbs and 102 limbs
ere treated by MT because revascularization was deemed
ot immediately necessary (n  21), primary missing con-
ent to any intervention (n  33), or local disease was
onsidered to be inaccessible for both surgery and PTA
n  48). In the MT-cohort, delayed arterial revascular-
zation was performed in 24 limbs (26%) after a median
f 49 days (range, 1-327 days) because of patient’s
hange of mind about initial refusal (n  5), change of
linical situation in patients initially deemed to be not
flow chart.rgent (n  15), or improved general condition either
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therapy reasonable (n  1).
Patient characteristics
Baseline characteristics stratified by gender. Com-
pared with men, women had a higher mean age at time of
CLI diagnosis (78 10 vs 73 11; P .001), and showed
higher systolic blood pressure (P  .03) and cholesterol
levels compared to men (P  .02; Table I). In contrast,
female patients smoked less (P  .001) and women pre-
sented with lower rates of renal failure (P  .03).
Men presented with slightly more Rutherford stage 5
lesions compared with women (P .04; Table II). Impor-
tantly, hemodynamic measurements, including ABI, oscil-
lometric readings, toe pressure, and TcPO2 as well as
localization and number of lesions treated were comparable
in both groups (P  not significant [ns]; Table II).
Baseline characteristics of the medical therapy and
immediate revascularization cohort. Patients with criti-
cal ischemic limbs of the MT group were less likely to have
diabetes (P  .03) and presented with lower toe pressures
(P  .001), but were similar with respect to gender, age,
other risk factors, or clinical presentation at baseline (P 
ns) compared to the immediate revascularization group
(Table III).
Primary end point analysis
Overall survival and amputation-free survival of
immediate revascularization vs medical therapy in the
overall critical limb ischemia cohort. In all patients with
CLI, irrespective of gender, immediate revascularization
resulted in a better overall survival rate (P  .04; Figs 2, A
and 3, A) and amputation-free survival (P  .02; Figs 2, B
Table I. Risk factors, laboratory measurements, and medi
Characteristic
To
(n 
Risk factors
Age, years, mean (SD) 75 (1
Hypertension, % (n) 77 (2
Systolic blood pressure, mm Hg, mean (SD) 143 (2
Diastolic blood pressure, mm Hg, mean (SD) 74 (1
Hyperlipidemia, % (n) 59 (1
Cholesterol (mmol/L, median IQR) 5.1 (4
Smoking, % (n) 53 (1
Diabetes, % (n) 48 (1
Renal failure, % (n) 26 (9
Creatinine (mmol/L, median IQR) 102 (8
Dialysis, % (n) 7 (2
Homocysteine (mmol/L, median IQR) 17 (1
Fibrinogen (g/L, median IQR) 3.9 (3
Platelet inhibitor, % (n) 54 (1
Anticoagulation, % (n) 30 (1
Baseline demographics, including risk factors and medical therapy of 356 pat
from univariable linear or logistic regression models that accounted for th
variables are reported as mean (SD), asymmetrically distributed variables as m
95% confidence intervals are two-sided.
IQR, Interquartile range.and 3, B) compared to MT. Multivariable analysis did not mhange these outcomes for overall survival (P .04; Fig 3,
), or amputation-free survival (P .03; Fig 3, B) favoring
mmediate revascularization compared to MT.
Overall survival and amputation-free survival of
mmediate revascularization compared to medical ther-
py in men and women with critical limb ischemia. As
ompared to MT, immediate revascularization showed a
ore pronounced beneficial effect on overall survival
P  .01; Figs 2, C and 3, A) and amputation-free
urvival (P  .01; Figs 2, D 3, B, and 4, A) in women.
he effect on amputation-free survival was consistent
fter multivariable adjustment (P  .02; Fig 3, B),
hereas significance was lost for overall survival (P 
07; Fig 3, A). In male patients, we did not observe
ifferences in rates of overall and amputation-free sur-
ival comparing immediate revascularization vs MT in
nivariable and multivariable analysis (Figs 2, E and F, 3,
, and 3, B). A significant gender difference was ob-
erved for amputation-free survival (P  .03; Fig 4)
rrespective of revascularization modality; however, sig-
ificance was lost after adjustment (P  .23).
econdary end point analysis
Limb salvage and sustained clinical success of im-
ediate revascularization vs medical therapy in the
verall critical limb ischemia cohort. Limb salvage was
ot significantly changed by immediate revascularization in
he overall cohort as compared to MT (P  .14; Fig 3, C).
n contrast, compared to MT, the overall cohort benefited
rom immediate revascularization concerning sustained
linical success (P  .02 after adjustment; Fig 3, D).
Limb salvage and sustained clinical success of im-
erapy of 356 patients at baseline presented by gender
Male patients
(n  207)
Female patients
(n  149) P value
73 (11) 78 (10)  .001
73 (151) 82 (122) .05
141 (27) 147 (26) .03
75 (12) 72 (12) .05
56 (94) 62 (77) .36
) 4.9 (4.2-5.8) 5.3 (4.3-6.3) .02
72 (148) 28 (41)  .001
50 (104) 44 (65) .20
31 (60) 21 (30) .03
) 105 (87-140) 99 (83-124) .06
8 (16) 5 (8) .38
17 (14-23) 17 (15-23) .77
) 3.9 (3.2-5.0) 4.0 (3.4-4.9) .66
53 (109) 55 (82) .66
32 (66) 27 (40) .31
ith 394 critical ischemic limbs stratified by gender using Wald tests derived
ering of limbs within patients. Continuous data and normally distributed
(IQR), and categorical variables as percentages (numbers). All P values andcal th
tal
356)
1)
73)
7)
2)
71)
.3-6.0
89)
69)
0)
5-131
4)
4-23)
.3-5.0
91)
06)
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though not significant, there was a trend in favor of imme-
diate revascularization regarding limb salvage in female
patients (P  .09; Fig 3, C). Similar to the primary end
points, in women, immediate revascularization was associ-
ated with higher rates of sustained clinical success com-
pared to MT (P .01) but not in men (P .89; Fig 3,D).
When adjusted for risk factors, these beneficial effects of
early revascularization on sustained clinical success in fe-
male patients were still significant (P  .03).
Number of repeated target extremity revascular-
ization procedures and median follow-up time in men
and women with critical limb ischemia. More repeated
revascularization procedures (target extremity revascular-
izations) had to be performed in female patients compared
to male patients (34% vs 24%; P .04; Table IV), but there
was no difference in median follow-up time between gen-
ders (P  ns).
Overall survival and amputation-free survival ac-
cording to revascularization method used. In all pa-
tients, no differences between surgical or endovascular
treatment for overall survival (multivariable hazard ratio
[HR], 1.07; 95% CI, 0.51-2.24; P  .86; Appendix Fig 5,
online only) or amputation-free survival were observed
(multivariable HR, 0.95; 95% CI, 0.56-1.59; P  .84).
After multivariate analysis, there was a trend in female
Table II. Treatment modality, clinical presentation, hemo
critical ischemic limbs at baseline presented by gender
Characteristic
Total
(n  394)
Treatment modality
Medical therapy, % (n) 26 (102)
Immediate revascularization, % (n) 75 (292)
Surgery, % (n) 21 (81)
PTA, % (n) 54 (211)
Clinical presentation, % (n)
Rutherford 4, % (n) 18 (71)
Rutherford 5, % (n) 81 (381)
Rutherford 6, % (n) 1 (5)
Hemodynamic presentation
ABI, median (IQR) 0.37 (0.22-0.5
TcPO2, mm Hg, median (IQR) 6 (2-19)
Toe pressure, mm Hg, median (IQR) 20 (0-30)
Nonpulsatile oscillometric reading, % (n) 63 (243)
Number of segments with lesions
1, % (n) 45 (126)
2, % (n) 52 (144)
3, % (n) 3 (9)
Distribution of revascularized lesions
Lesion above knee, % (n) 78 (219)
Lesion below knee, % (n) 61 (171)
Baseline clinical presentation andmorphologic characteristics, hemodynamic
of lesions treated of 394 critical ischemic limbs stratified by gender usingWal
for the clustering of limbs within patients. Treated lesions were grouped as il
and deep femoral arteries), popliteal (popliteal artery) and infragenual seg
Continuous data and normally distributed variables are reported as mean (SD
as percentages (numbers). All P values and 95% confidence intervals are two
PTA, Percutaneous transluminal angioplasty; ABI, ankle-brachial index; IQpatients favoring surgery regarding overall survival (multi- Cariable HR, 0.47; 95% CI, 0.11-1.97; P  ns) and
mputation-free survival (multivariable HR, 0.53; 95% CI,
.19-1.46; P ns; Appendix Fig 5, online only), although
his effect was not statistically significant.
ISCUSSION
This prospective cohort study performed in a consecu-
ive series of patients with CLI shows that clinical outcome
f immediate revascularization is superior to MT with
ptional delayed revascularization as first-line therapy in
he overall population. However, the key finding of our
tudy is that immediate revascularization is essential for
igher survival rates and sustained clinical success in women
ith CLI, regardless of revascularization methods used.
ur data also demonstrate gender differences regarding
aseline characteristics at the time of presentation with
ncreased age, systolic blood pressure, and higher choles-
erol levels in female patients vs higher prevalence of renal
ailure and slightly worse clinical presentation in male pa-
ients. Importantly, these differences did not change
he beneficial effects of immediate revascularization on
mputation-free survival and sustained clinical success in
omen after multivariable analysis.
This report demonstrates that immediate revascular-
zation significantly improves amputation-free survival
nd sustained clinical success in women presenting with
mic measurements, and lesion morphology of 394
Male patients
(n  230)
Female patients
(n  164) P value
.45
26 (59) 26 (43)
74 (271) 74 (121)
18 (42) 24 (39)
56 (129) 50 (82)
.04
14 (32) 24 (39)
85 (196) 74 (122)
1 (2) 2 (3)
0.37 (0.00-0.55) 0.38 (0.26-0.48) .07
6 (2-17) 8 (2-20) .20
20 (0-30) 20 (0-25) .38
62 (141) 65 (102) .42
.38
46 (75) 44 (51)
52 (84) 51 (60)
2 (3) 5 (6)
75 (122) 83 (97) .13
65 (105) 56 (66) .16
cteristics, treatment modality, number of segments with lesions and number
derived from univariable linear or logistic regression models that accounted
oral (common, external, and internal iliac artery, and common, superficial,
s (tibiofibular trunk, anterior and posterior tibial arteries, fibular artery).
mmetrically distributed variables as median (IQR), and categorical variables
.
erquartile range; TcPO2, transcutaneous oxygen tension.dyna
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Volume 54, Number 6 Ortmann et al 1673cardiovascular risk factors. Technical feasibility, safety,
and interventional success of arterial revascularization
have been established for the treatment of CLI.2-7,25-27
However, revascularization trials have rendered female
gender as a major risk factor for loss of graft patency and
major amputation after surgical revascularization, wound
complications, as well as lower stent patency rates.4-6,8
Therefore, and in contrast to the findings of our present
study, benefit from arterial revascularization in female pa-
tients with CLI has been questioned.28 Because these stud-
ies only investigated patients treated by either surgical or
endovascular means,4-6,8 they are, however, not represen-
tative for an “all-comers” CLI population. The beneficial
effect of immediate revascularization in women with CLI
seen in our series parallels studies demonstrating that fe-
male patients with acute coronary syndromes at high risk
profit from immediate invasive management, possibly even
more than men.29,30 These findings led to gender-specific
American College of Cardiology/American Heart Associ-
ation recommendations, namely that in women with acute
coronary disease, immediate revascularization should be
performed, whereas in women with less severe disease,
conservative treatment is recommended.16 Because of the
lack of data, there have been no recommendations for the
Table III. Baseline characteristics of 394 critical ischemic
modality
Medical thera
revascula
Risk factors
Number of females, % (n) 4
Age, years, mean (SD) 74
Hypertension, % (n) 7
Systolic blood pressure, mm Hg, mean (SD) 139
Diastolic blood pressure, mm Hg, mean (SD) 73
Hyperlipidemia, % (n) 5
Cholesterol, median (IQR) 4
Smoking, % (n) 5
Diabetes, % (n) 3
Renal insufficiency, % (n) 2
Creatinine, median (IQR) 10
Dialysis, % (n)
Homocysteine, median (IQR) 17
Fibrinogen, median (IQR) 3
Platelet inhibitor, % (n) 5
Anticoagulation, % (n) 3
Clinical presentation
Rutherford 4, % (n) 2
Rutherford 5, % (n) 7
Rutherford 6, % (n)
Hemodynamic presentation
ABI, median (IQR) 0
TcPO2, mm Hg, median (IQR)
Toe pressure, mm Hg, median (IQR)
Nonpulsatile oscillometric reading, % (n) 1
Demographic data of 394 critical ischemic limbs of 356 patients. Baseline
therapy usingWald tests derived from univariable linear or logistic regression
and normally distributed variables are reported as mean (SD), asymmetrical
(numbers). All P values and 95% confidence intervals are two-sided.
IQR, Interquartile range; ABI, ankle-brachial index; TcPO2, transcutaneoustreatment of women with CLI yet. However, our data iuggest an immediate revascularization strategy in female
atients with CLI.
There are very few data concerning rates of revascular-
zation in women with CLI,31 which impede a direct com-
arison of studies. In our analysis, the number of patients
eceiving MT, PTA, or surgery was equally distributed
etween men and women, suggesting that there was no
ender disparity concerning access to treatment.
The major factor for the beneficial outcome of im-
ediate revascularization in women may be the
lose follow-up we provided for our patients with regular
ostinterventional visits in our institution at 2, 6, and 12
onths. Therefore, the proposed increased risk of surgical
ound complications in women with CLI5 may have been
eneficially influenced by the close surveillance of a profes-
ional wound care team at our department, possibly result-
ng in higher amputation-free survival rates as observed in
ur female patients.1,25 One finding of our study was that
he advantageous effect of immediate revascularization in
omen was obtained by an aggressive reintervention regi-
en, since slightly more TERs were observed in women.
mportantly, the proportion of men and women receiving
evascularization by surgical or endovascular means was
qually distributed. Therefore, the higher incidence of re-
s at first presentation with stratification for treatment
th optional delayed
ion (n  102)
Immediate revascularization
(n  292) P value
3) 41 (121) .90
2.1) 75.6 (10.1) .43
5) 78 (227) .41
8.4) 143.5 (27.2) .21
2.6) 73.3 (12.5) .83
9) 58 (145) .39
.1-5.9) 5.1 (4.3-6.0) .56
2) 54 (158) .64
8) 50 (147) .03
2) 29 (82) .38
4-125) 104 (87-138) .28
) 8 (22) .55
5.0-22.0) 17.0 (14.5-22.5) .72
.2-4.8) 4.0 (3.4-5.2) .66
6) 52 (152) .63
7) 28 (82) .13
.15
2) 17 (49)
0) 82 (238)
) 2 (5)
.2-0.5) 0.4 (0.2-0.5) .70
-20) 6 (2-18) .06
-10) 23 (0-35)  .001
3) 57 (20) .15
teristics were compared between immediate revascularization and medical
s that accounted for the clustering of limbs within patients. Continuous data
ributed variables as median (IQR), and categorical variables as percentages
en tension.limb
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2 (4
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December 20111674 Ortmann et alFig 2. Kaplan-Meier survival curves for cumulative outcome estimates of primary efficacy study end points for overall
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rate in women with CLI after endovascular therapy.4 How-
ever, repeated interventions represent an important eco-
nomical issue because women have a longer life expectancy
and repeated interventions may exceed the costs of surgical
revascularization in the long-term.32 In this regard, the
choice of an immediate invasive vs MT strategy for CLI
should be based on objective risk stratification measures
and immediate revascularization should be restricted to
compliant patients where diligent surveillance and addi-
tional reinterventions are feasible as needed.
Importantly, the significant positive effect of immedi-
ate revascularization in women on sustained clinical success
and amputation-free survival persisted when multivariable
analysis was performed. This suggests that in female pa-
tients immediate revascularization is an independent deter-
Fig 3. Forest plots from univariable (left panels) and m
that accounted for the clustering of limbs within patien
medical therapy (MT) with optional delayed revasculari
limb salvage (C), and sustained clinical success (D) se
Multivariable Coxmodels were adjusted for age, diabetes,
intake of anticoagulants or platelet inhibitors, and clinica
were calculated using two-sided Wald test derived fromminant for improved outcome. The finding that the signif- ncant difference regarding overall survival was lost when
ata were adjusted may implement the impact of cardiovas-
ular risk factors and baseline clinical presentation on over-
ll survival. In our study, gender differences of cardiovas-
ular risk factors included age, the prevalence of renal
ailure, smoking habits, cholesterol levels, and systolic
lood pressure. The higher mean age observed in women,
ell in accordance with previous studies,4,6,9,10,33 might be
ue to a later onset of disease, possibly resulting from the
rotective effects of endogenous estrogens before meno-
ause.12 Moreover, women are frequently principal care-
ivers for others, may be more distrustful of health care
roviders, andmight therefore present at a higher mean age
han men.34 Importantly, because there is an insurance
bligation in Switzerland, insurance status should not be a
atter of gender disparities in this study. Moreover, the
ariable (right panels) Cox proportional hazard models
compare the effects of immediate revascularization vs
on overall survival (A), amputation-free survival (B),
ely for all patients, for female and for male patients.
rtension, smoking, renal failure, dialysis, hyperlipidemia,
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December 20111676 Ortmann et alequally distributed betweenmen andwomen, ensuring that
there was no gender disparity concerning access to treat-
ment.
The lower prevalence of renal failure35,36 and the lower
frequency of smoking among women with CLI is also well
in accordance with previous studies.33 Moreover, female
patients may have received less effective treatment of car-
diovascular risk factors prior to admission.33,37 This notion
is supported by the finding that women had higher systolic
blood pressure and total cholesterol levels at the time of
presentation in our study. Finally, it is important to note
that no significant differences in hemodynamic measure-
ments of the target limb as well as lesion location or number
of lesions were observed between men and women. Thus,
equal clinical features of CLI in both patient groups allow a
conclusive analysis of gender differences in our study.
The finding that immediate revascularization did not
show beneficial effects in men may be due to the fact that
the cardiovascular risk profile was different between gen-
ders. Obviously, there were more smokers among men
compared to women. Smoking strongly correlates with
higher cardiovascular mortality and restenosis rates after
infragenual revascularization.38 Additionally, we observed
a higher proportion of renal failure among men, which is in
concert with other CLI cohorts.35,36 Renal failure is asso-
ciated with very distal lesions in which revascularization is
challenging and accordingly associated with poor overall
outcome in CLI.4 Moreover, renal failure has been shown
to be more frequently associated with drug overdose and
contrast-induced nephropathy and with diffuse vascular
calcinosis, accompanied with higher mortality.39 Most im-
portantly, and possibly explaining the lack of effect of
Fig 4. Kaplan-Meier-survival curves for cumulative outcome es-
timates of immediate revascularization on efficacy study end point
for amputation-free survival calculated separately for women and
for men. The P values were calculated using two-sided Wald test
derived fromCox proportional hazard models. Numbers at risk are
given for limbs.immediate revascularization, may be the finding that male gatients tended not to adhere to the strict follow-up regi-
en as much as our female patients. This was associated
ith less reinterventions in men compared to women,
hich again emphasizes the need for regular surveillance
nd an “aggressive” approach, including multiple reinter-
entions in patients with CLI treated by an immediate
nvasive strategy.
Recently, a prospective, randomized, controlled multi-
enter trial (Bypass versus Angioplasty in Severe Ischemia
f the Leg), showed that neither surgery first or angioplasty
rst as treatment for severe limb ischemia was superior to
he other.7 Indeed, data of this trial are in line with our
tudy showing no differences in overall and amputation-
ree survival in the overall population regarding the revas-
ularization method used. Unfortunately, no analysis con-
erning gender differences was performed in this trial.7
mportantly, in our study, there were no significant differ-
nces concerning overall and amputation-free survival in
en and women with CLI. Therefore, we may conclude
hat endovascular treatment should be considered equiva-
ent to surgical revascularization in severe lower limb isch-
mia of male and female patients. Accordingly, the optimal
evascularization strategy should be discussed interdisci-
linary for each individual patient based on lesionmorphol-
gy and comorbidities, as well as socioeconomic factors.
Limitations. Patients of this prospective cohort study
ere not randomized to treatment, since randomization of
atients with CLI to MT is an ethical concern because
mmediate revascularization is currently considered as the
reatment of choice. Further, the consistency of the treat-
ent decision is a matter of concern. Yet, assessment of
ach individual patient was performed by our multidisci-
linary vascular board, in which consultants did not change
uring the study period. Moreover, proportions of our
atients receivingMT as the primary treatment (25% in our
eries) were very well in accordance with the TransAtlantic
ntersociety Consensus II document on management of
eripheral artery disease.40
Another limitation of our study is the heterogeneity of
he MT cohort, which included both patients suitable and
ot suitable for immediate revascularization. Patients suit-
ble for immediate revascularization either initially declined
n invasive treatment or revascularization was not consid-
red as urgently necessary. Therefore, a relatively high
ercentage of patients of our MT group received delayed
ntervention but were kept in theMTgroup for the purpose
f an intention-to-treat analysis.
All of the above-mentioned limitations may lead to
election bias. Therefore, immediate revascularization and
T groups were reanalyzed for therapy actually received
ithin the first month after CLI diagnosis (data not
hown). Importantly, we found similar effects in our pri-
ary and secondary end point analysis, justifying our re-
ults. Of note, except from toe pressure, which was lower in
he MT group, patient characteristics such as risk factors or
isease severity were similar in the immediate revasculariza-
ion and MT group, illustrating comparability of both
roups.
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1-year follow-up only. Commonly, after 1-year, follow-up
was taken over by the general physician because follow-up
visits at our tertiary referral center are difficult to arrange for
most of our elderly patients with limited mobility. More-
over, all patients with a first time CLI diagnosis were
enrolled irrespective of any history of revascularization.
Therefore, we might have missed lesions from former re-
vascularization procedures, which also might have influ-
enced treatment decisions.
In the light of the current finding that women benefit
from immediate revascularization, it is important to guar-
antee that both genders have equal access to revasculariza-
tion therapy. Because socioeconomic status was not as-
sessed, it is important to note that the proportion of male
and female patients in our study is similar to other CLI
cohorts,6,7 andmen and women were equally distributed in
the MT group as well as in the immediate revascularization
group.
CONCLUSION
This study shows that important differences exist re-
garding baseline characteristics between women and men
with CLI. The hypothesis that higher procedural compli-
cations, comorbidities, and less severe disease at clinical
presentation may favor MT with optional delayed revascu-
larization in women is not supported by our data. In fact,
the findings of this prospective trial reveal that women with
CLI benefit from an immediate revascularization compared
toMT and, thus, our data suggest aggressive and early limb
salvage efforts in women with CLI.
We thank Jolanda Vögele and Ackaterini Galimanis for
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Table IV. Median follow-up time and repeated revascular
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